Compare BioNTech SE - ADR (BNTX) vs Celestica Inc (CLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Celestica Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Celestica Inc trades at $318.84 (market cap $39.16B). The key difference: Celestica Inc is the larger of the two by market cap, and Celestica Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | CLS | |
|---|---|---|
Market Cap | $23.31B | $39.16B |
Sector | Health | Technology |
52-Week High | $119.34 | $472.40 |
52-Week Low | $83.89 | $181.34 |
Enterprise Value | $6.60B | $39.44B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Celestica Inc
Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →
